Lilly Ventures had been part of consortium investing about $70m in Avid Radiopharmaceuticals, which is now being acquired by Eli Lilly for up to $800m.

Vericare is backed by Aetna Ventures, the corporate venturing division of healthcare provider Aetna, and is raising debt to bolt on peer.

Provident Healthcare Ventures to manage the inaugural $25m Principals Fund I.

Medtronic backs Intersect ENT's $30m round.

Mitsui & Company Venture Partners strikes Irish med-tech deal in Cappella.

Venture capital firm CHL Medical Partners leads B round for Vascular Pathways, a US-based medical device company also backed by Ascension Health Ventures.

Japan-based drugs company Takeda Pharmaceutical rebrands venturing unit Takeda Ventures.

Pacific Biosciences prices 12.5 million common shares at $16 each compared to $15 to $17 it set ahead of its initial public offering, and has a market capitalization of $802m on the Nasdaq stock exchange.

Linde, which owns 17% of Ikaria as part of a $380m cash-and-stock sale in 2007 of its gaseous drug-maker, INO Therapeutics, will see its stake diluted to 13.2% after the IPO.